iRhythm Technologies will present at multiple investor conferences in June 2025, showcasing its digital health solutions.
Quiver AI Summary
iRhythm Technologies, Inc. announced that its management team will present at several upcoming investor conferences, including the William Blair Annual Growth Stock Conference on June 4, the Goldman Sachs Global Healthcare Conference on June 10, and the Truist Securities MedTech Conference on June 17. The presentations will be accessible live and in archived format on the company’s investor website. iRhythm is a digital health care company that develops solutions to detect, prevent, and predict disease through the use of wearable biosensors and cloud-based analytics. Their goal is to enhance patient care by providing better data and health insights.
Potential Positives
- iRhythm Technologies is scheduled to present at three prominent investor conferences, indicating strong interest and confidence in the company from financial markets.
- The participation in these conferences provides iRhythm with a platform to showcase its innovative solutions and promote engagement with potential investors.
- Access to live and archived webcasts broadens the opportunity for interested parties to engage with the company's presentations, potentially enhancing investor relations.
Potential Negatives
- None
FAQ
What upcoming investor conferences will iRhythm Technologies attend?
iRhythm Technologies will present at the William Blair, Goldman Sachs, and Truist Securities conferences in June 2025.
How can I access iRhythm's conference presentations?
Live and archived webcasts of iRhythm's presentations can be accessed on their investor website in the “Events & Presentations” section.
What is the focus of iRhythm Technologies?
iRhythm Technologies focuses on creating solutions that detect, prevent, and predict disease using wearable biosensors and data analytics.
Who are the key contacts for iRhythm Technologies?
The investor contact is Stephanie Zhadkevich, and the media contact is Kassandra Perry.
When is iRhythm's presentation at the Goldman Sachs conference?
iRhythm's presentation at the Goldman Sachs conference is scheduled for June 10, 2025, at 2:40 p.m. Eastern Time.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$IRTC Insider Trading Activity
$IRTC insiders have traded $IRTC stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $IRTC stock by insiders over the last 6 months:
- CHAD PATTERSON (Chief Commercial Officer) has made 0 purchases and 4 sales selling 22,200 shares for an estimated $2,564,115.
- QUENTIN S. BLACKFORD (President and CEO) sold 22,252 shares for an estimated $2,495,116
- PATRICK MICHAEL MURPHY (CBO and CLO) has made 0 purchases and 3 sales selling 18,822 shares for an estimated $2,005,079.
- SUMI SHRISHRIMAL (EVP, Chief Risk Officer) sold 7,942 shares for an estimated $890,536
- MINANG TURAKHIA (EVP, CMO & CSO) sold 7,014 shares for an estimated $786,479
- DANIEL G. WILSON (Chief Financial Officer) has made 0 purchases and 2 sales selling 4,512 shares for an estimated $531,670.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IRTC Hedge Fund Activity
We have seen 130 institutional investors add shares of $IRTC stock to their portfolio, and 141 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 568,261 shares (+169.7%) to their portfolio in Q1 2025, for an estimated $59,485,561
- CAPITAL RESEARCH GLOBAL INVESTORS added 565,596 shares (+34.6%) to their portfolio in Q1 2025, for an estimated $59,206,589
- FULLER & THALER ASSET MANAGEMENT, INC. added 518,240 shares (+inf%) to their portfolio in Q1 2025, for an estimated $54,249,363
- POINT72 ASSET MANAGEMENT, L.P. added 420,303 shares (+inf%) to their portfolio in Q1 2025, for an estimated $43,997,318
- FIERA CAPITAL CORP removed 381,644 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $34,412,839
- ALYESKA INVESTMENT GROUP, L.P. removed 351,745 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $36,820,666
- MILLENNIUM MANAGEMENT LLC added 339,529 shares (+563.8%) to their portfolio in Q1 2025, for an estimated $35,541,895
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IRTC Analyst Ratings
Wall Street analysts have issued reports on $IRTC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 05/02/2025
- Oppenheimer issued a "Outperform" rating on 01/08/2025
To track analyst ratings and price targets for $IRTC, check out Quiver Quantitative's $IRTC forecast page.
$IRTC Price Targets
Multiple analysts have issued price targets for $IRTC recently. We have seen 2 analysts offer price targets for $IRTC in the last 6 months, with a median target of $133.0.
Here are some recent targets:
- Richard Newitter from Truist Financial set a target price of $146.0 on 05/05/2025
- Suraj Kalia from Oppenheimer set a target price of $120.0 on 01/08/2025
Full Release
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) --
iRhythm Technologies, Inc.
(NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor conferences.
William Blair 45
th
Annual Growth Stock Conference
on Wednesday, June 4, 2025, at 2:00 p.m. Central Time (12:00 p.m. Pacific Time)
Goldman Sachs 46
th
Annual Global Healthcare Conference
on Tuesday, June 10, 2025, at 2:40 p.m. Eastern Time (11:40 a.m. Pacific Time)
Truist Securities MedTech Conference
on Tuesday, June 17, 2025, at 1:40 p.m. Eastern Time (10:40 a.m. Pacific Time)
Interested parties may access live and archived webcasts of the presentations on the “Events & Presentations” section of the company’s investor website at
investors.irhythmtech.com
.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all. For additional information about iRhythm, please visit its corporate website at
irhythmtech.com
.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
irhythm@highwirepr.com
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
